Insights from factor IX activation studies with chromogenic assays: implications of disparate product results.
Barrowcliffe
T W
TW
National Institute for Biological Standards and Control, Potters Bar, UK. twbarrowcliffe@yahoo.co.uk
D001682:Biological Availability; D001780:Blood Coagulation Tests / Q000379:methods*; D002863:Chromogenic Compounds; D004789:Enzyme Activation; D005164:Factor IX / Q000378:metabolism* / Q000493:pharmacokinetics; D006801:Humans
D002863:Chromogenic Compounds; D005164:Factor IX